A New Method Extracts DNA From Soil Bacteria That Cannot Be Grown in a Lab

Introduction: the hidden face of the microbial world

An almost entirely invisible reservoir

The vast majority of soil bacteria stubbornly refuse to grow in a laboratory Petri dish. Microbiologists have known this for a long time, and it means that the overwhelming majority of the microbial diversity present in soil remains completely inaccessible to researchers, despite decades of attempts at culturing under artificial conditions in laboratories around the world.

This fact is not trivial given the current context: as antibiotic resistance spreads dangerously worldwide, this vast reservoir of unculturable microbes potentially represents an untapped source of new therapeutic molecules, capable of renewing a medical arsenal increasingly vulnerable to infections that are ever more resistant to existing treatments.

This situation puts researchers in a frustrating bind: they know the solution to the antibiotic crisis probably lies within this hidden microbial biodiversity, but the traditional tools of microbiology simply do not let them access it in a systematic and reliable way.

The lab that chose to work around the obstacle

Faced with this technical roadblock, the laboratory led by researcher Sean F. Brady chose a radically different approach: rather than trying, once again, to culture these stubborn bacteria, the team developed a method for directly extracting large DNA fragments from soil samples, without ever needing to grow the organisms themselves in a lab.

This approach, announced in 2025, fits into a broader research effort aimed at revealing the genomes of microbes previously completely inaccessible to science, drawing on increasingly sophisticated and precise genetic extraction techniques developed specifically for this kind of complex sample.

The fundamental goal of this approach is to bypass entirely the culturing step, long considered unavoidable in microbiology. By working directly on environmental DNA extracted from soil, the Brady team frees itself from the constraints that had previously blocked the study of nearly all microorganisms present in a given sample.

How this new extraction technique works

Capturing large DNA fragments directly from soil

The method developed by the Brady team extracts DNA fragments that are much longer than what previous techniques allowed. This difference in size is crucial: the longer a genetic fragment is, the more likely it is to contain a complete set of genes needed to manufacture a complex molecule, such as a natural antibiotic produced by a soil bacterium.

With earlier techniques, the fragments recovered were often too short and fragmented to reconstruct entire metabolic pathways, which considerably limited researchers' ability to understand, and then exploit, the biochemical potential of these unculturable soil microorganisms, often responsible for producing complex chemical compounds.

This technical limitation had considerably held back the field for years. A single isolated gene, cut off from the rest of its biosynthetic pathway, generally does not allow researchers to understand how a bacterium builds a complex molecule, much as it would be impossible to reconstruct a recipe from a single listed ingredient without the rest of the instructions.

Reconstructing complete bacterial genomes

Thanks to this new approach, the team was able to assemble hundreds of complete bacterial genomes directly from soil samples, without ever needing to physically culture a single one of these organisms in a lab. This unusually high figure illustrates the scale of the potential unlocked by this genetic extraction method applied at scale.

Each of these reconstructed genomes forms a kind of complete molecular blueprint, revealing the full set of genetic instructions held by the corresponding bacterium, including those coding for the manufacture of molecules potentially useful to human medicine, such as certain natural antibiotics never before described.

This ability to reconstruct hundreds of genetic blueprints in a single research campaign represents a considerable change of scale compared with traditional methods, which rarely allowed the study of more than a handful of culturable organisms at a time.

From raw DNA to the first antibiotic candidates

Turning a genetic blueprint into a real molecule

Having a bacterium's complete genome is not enough: you still need to be able to turn this abstract genetic information into an actual usable chemical molecule for medicine. This is precisely the next step the Brady team took, pushing the work well beyond simple genomic data collection to reach the actual synthesis of compounds.

As a proof of concept, the researchers used this method to convert some of these genetic blueprints into real molecules, produced in the lab from instructions extracted directly from soil, without ever going through the culturing of the original bacterium itself.

This synthesis step relies on molecular biology techniques that insert the identified genes into a host organism capable of expressing them, meaning following the genetic instructions to actually produce the targeted molecule, even in the total absence of the original, unculturable bacterium.

Two promising antibiotic candidates

This work led to the identification of two antibiotic candidates the research team considers promising. In the words of researcher Brady himself, the team now has the technology needed to observe a microbial world previously inaccessible to humanity, and it is not merely observing this information: it is already turning it into potentially useful antibiotics for the medicine of tomorrow.

Brady also described these results as merely the tip of the iceberg, suggesting that this extraction method could, over time, reveal a far larger number of still-unknown therapeutic molecules, hidden within the extraordinary microbial diversity present in soils around the world.

These two candidates still need to clear numerous validation steps, including toxicity testing and efficacy trials against resistant bacterial strains, before any clinical development can be considered. But their mere existence already demonstrates the concrete viability of this novel methodological approach, in a field where most previous attempts never managed to move beyond the purely theoretical stage of genetic identification.

Why this advance matters in the fight against bacterial resistance

A worsening global health crisis

Antibiotic resistance is one of the most serious health threats identified by health authorities around the world. Year after year, a growing number of bacterial infections become harder, or even impossible, to treat with currently available molecules, making it urgent to discover new classes of antibiotics effective against these resistant strains.

Yet the discovery of new antibiotics has slowed considerably over recent decades, largely because easily accessible natural sources, notably lab-culturable bacteria, have already been extensively explored by the pharmaceutical industry and university laboratories worldwide over several generations of researchers.

This slowdown deeply worries health authorities, who fear a scenario in which infections that are mild today could become potentially deadly again for lack of effective available treatments, much as was the case before the discovery of the first antibiotics in the twentieth century.

A scalable path toward the untapped microbial majority

This is precisely what makes the Brady lab's method so significant: it opens a potentially repeatable and scalable path toward exploring this majority of microbes that has, until now, remained out of reach. Rather than being limited to a few soil samples analyzed on a one-off basis, this approach could be applied systematically to soils from very diverse regions of the world, from tropical forests to arid land.

This prospect opens the possibility of genuine large-scale screening of global microbial diversity, with the hope of discovering dozens, or even hundreds, of new molecules capable of reinforcing a therapeutic arsenal currently weakened by the spread of bacterial resistance around the world.

Each type of soil, with its own particular chemical composition and climate, potentially harbors distinct microbial communities carrying unique molecules never encountered elsewhere. It is this geographic diversity that makes the systematic application of this method particularly promising for future pharmaceutical discovery, as genetic sequencing costs continue to fall and computational analysis capabilities keep advancing.

Conclusion: rediscovering the ground beneath our feet

A long-neglected resource

This advance from Sean F. Brady's laboratory is a reminder of a simple but often forgotten truth: a huge share of our planet's microbial biodiversity remains completely unknown, even though it lies literally beneath our feet, in the soil we walk on every day without giving it a second thought.

By developing a method able to bypass the historic obstacle of laboratory bacterial culturing, this team has opened a new window onto a microscopic world that had remained invisible, with potentially major implications for future medicine and global public health.

This kind of research also highlights the importance of preserving soil biodiversity at the planetary scale, an ecological issue often overshadowed by more visible environmental concerns. Degraded or contaminated soil could, without anyone noticing, wipe out therapeutic molecules that science will never have had the chance to discover.

A partial, but essential, answer to a global crisis

Given the worrying rise of bacterial resistance, every new therapeutic lead counts. This research alone will not solve the global antibiotics crisis, but it demonstrates that largely untapped reservoirs of potential solutions still exist, provided the technological tools needed to access them efficiently and quickly are developed.

The coming years will tell whether the two antibiotic candidates identified by the Brady team manage to clear the demanding stages of pharmaceutical development, up to possible clinical trials. But beyond these two specific molecules, it is above all the method itself, repeatable and applicable at scale, that represents the true promise of this scientific advance for the future of anti-infective medicine.

By Maxime Marquette, columnist

Columnist's transparency note

Sources behind this piece

This piece is based on Rockefeller University's public communications about its 2025 discoveries and on outlets covering microbial genomics and antibiotic research. I am not a microbiologist, and I have relied on the researchers' own statements about what their method has achieved so far, rather than speculating about timelines for clinical use.

I have deliberately kept the framing modest regarding the two antibiotic candidates, since the researchers themselves stress that extensive validation work remains ahead before any clinical application becomes possible. Where the science reporting used technical shorthand, I have tried to spell out what each term actually means for a reader who has no background in microbiology or genomics.

Sources

Primary sources

The Rockefeller University — Intriguing science discoveries of 2025, including DNA extraction from soil bacteria — 2025

Nature — Antibiotics: scientific publications on bacterial resistance and new molecules — 2025

Cell Press — Research on microbial genomics and antibiotic discovery — 2025

Secondary sources

Futura Sciences — Accessible analysis of soil microbiology and antibiotics — 2025

Sciences et Avenir — Coverage of advances in antibiotic resistance — 2025

Pour la Science — Reports on environmental genomics and the fight against bacteria — 2025